Exchange: NASDAQ·Updated 12:52 PM EDT
CGON logo

CGON Cg Oncology Inc.

$74.19
$0.15
(0.20%)
Today
Reported EarningsAug 6
Mkt Cap$6.59B
Vol312,854.00

About CGON

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Dallas, TX.
53

Neutral Sentiment

How do you feel about CGON?

Advertisement|Remove ads.